feed,title,long_url,short_url
Benzinga,Exicure Stock Surges On Over $1B Option Licensing Pact With Ipsen For Rare Neurodegenerative Disorders,https://benzinga.com/general/biotech/21/08/22269721/exicure-stock-surges-on-over-1b-option-licensing-pact-with-ipsen-for-rare-neurodegenerative-disor,https://j.mp/3xnFs89
